Clinical outcome of tyrosine kinase inhibitors alone or combined with radiotherapy for brain metastases from epidermal growth factor receptor (EGFR) mutant non small cell lung cancer (NSCLC)

Qianqian Zhu(Zhengzhou University), Hong Ge(Nanfang Hospital), Jie Ma(Zhengzhou University), Xiao Liu(Beijing Forestry University), Ke Ye(Zhengzhou University), Jinming Yu(Shandong University), Daoke Yang(First Affiliated Hospital of Zhengzhou University), Chengliang Yang(Zhengzhou University), Yanan Sun(Zhengzhou University), Yingying Cui(Anhui Medical University)
Oncotarget
January 5, 2017
Cited by 46


Related Papers